Home › NDC Lookup › RxCUI directory › RxCUI 2052826

24 HR methylphenidate hydrochloride 72 MG Extended Release Oral Tablet [Relexxii] — RxCUI 2052826

RxNorm drug concept · Semantic branded drug
RxCUI 2052826 Semantic branded drug · SBD ● Current RxNorm concept 7 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2052826
Official name24 HR methylphenidate hydrochloride 72 MG Extended Release Oral Tablet [Relexxii]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as24 HR Relexxii 72 MG Extended Release Oral Tablet; RELEXXII 72 MG 24HR Extended Release Oral Tablet
FDA products mapped7
Package NDCs mapped11
Reported Medicaid activity (SDUD)712 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Methylphenidate Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Yes, location matters. Apply the patch to the hip area — not the waist, arm, or back. The clinical studies that established how well and how safely the patch works were done specif...
  • Where exactly do I put the patch and does it matter?
  • Water exposure — from bathing, swimming, or showering — can affect how well the patch sticks. If the patch partially or fully comes off, don't try to re-stick it with tape or adhes...
  • Can my child shower or swim while wearing the patch?
📖 Read our full Methylphenidate Transdermal Patch guide →

🕸️ Concept Web — How 24 HR methylphenidate hydrochloride 72 MG Extend... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR methylphenidate hydrochloride 72 MG Extended Release Oral Tablet [Relexxii] RxCUI 2052826

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Methylphenidate 6901
    • Methylphenidate hydrochloride 203188
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Relexxii 2052821
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Methylphenidate Extended Release Oral Tablet 372862
    • Methylphenidate hydrochloride Extended Release Oral Tablet 2649135
    • Methylphenidate Oral Product 1163482
    • Methylphenidate Pill 1163483
    • Methylphenidate hydrochloride Oral Product 2661865
    • Methylphenidate hydrochloride Pill 2659123
    • Methylphenidate Extended Release Oral Tablet [Relexxii] 2052823
    • Methylphenidate hydrochloride Extended Release Oral Tablet [Relexxii] 2654877
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 24 HR methylphenidate hydrochloride 72 MG Extended Release Oral Tablet SCD · 1995461
  • Methylphenidate hydrochloride 72 MG SCDC · 1091502
  • Methylphenidate Extended Release Oral Tablet SCDF · 372862
  • Methylphenidate hydrochloride Extended Release Oral Tablet SCDFP · 2649135
  • Methylphenidate Oral Product SCDG · 1163482
  • Methylphenidate Pill SCDG · 1163483
  • Methylphenidate hydrochloride Oral Product SCDGP · 2661865
  • Methylphenidate hydrochloride Pill SCDGP · 2659123

Brand-Name Concepts

  • Methylphenidate hydrochloride 72 MG [Relexxii] SBDC · 2052822
  • Methylphenidate Extended Release Oral Tablet [Relexxii] SBDF · 2052823
  • Methylphenidate hydrochloride Extended Release Oral Tablet [Relexxii] SBDFP · 2654877
  • Relexxii Oral Product SBDG · 2052824
  • Relexxii Pill SBDG · 2052825
  • Relexxii BN · 2052821

📦 FDA Products & Package NDCs

7 products · 11 package NDCs
11 package NDCs map to RxCUI 2052826 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68025-0084-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68025-084-30) RELEXXII Vertical Pharmaceuticals, LLC 2022-06-23
68025-0088-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68025-088-30) RELEXXII Vertical Pharmaceuticals, LLC 2022-06-23
68025-0089-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68025-089-30) RELEXXII Vertical Pharmaceuticals, LLC 2022-06-23
68025-0095-10 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68025-095-10) RELEXXII Vertical Pharmaceuticals, LLC 2023-11-01
68025-0095-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68025-095-30) RELEXXII Vertical Pharmaceuticals, LLC 2024-08-12
68025-0096-10 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68025-096-10) RELEXXII Vertical Pharmaceuticals, LLC 2023-11-01
68025-0096-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68025-096-30) RELEXXII Vertical Pharmaceuticals, LLC 2024-08-12
68025-0097-10 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68025-097-10) RELEXXII Vertical Pharmaceuticals, LLC 2023-11-01
68025-0097-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68025-097-30) RELEXXII Vertical Pharmaceuticals, LLC 2024-08-12
68025-0098-10 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68025-098-10) RELEXXII Vertical Pharmaceuticals, LLC 2023-11-01
68025-0098-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68025-098-30) RELEXXII Vertical Pharmaceuticals, LLC 2024-08-12
Observed labelers: Vertical Pharmaceuticals, LLC (11) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.